Trial intelligence / Profile preview

Comparison of vancomycin and teicoplanin in hospitalized children with severe pneumonia

IRCT2015030111145N13Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Mar 2015
Modality
Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
Countries
1
01

Overview

Phase 3 trial of vancomycin and teicoplanin in pneumonia (2 arms), sponsored by Kashan University of Medical Sciences. Started Mar 2015; status: completed.

02

Drugs

vancomycinteicoplanin
03

Conditions

pneumonia

Beyond the preview

Go deeper on IRCT2015030111145N13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015030111145N13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call